POTENTIAL APPLICATIONS IN OTHER INFLAMMATORY CONDITIONS Studies suggest possible therapeutic roles influencing chronic respiratory conditions, joint inflammation, and other immune system disorders
Research Considerations Outcomes may vary with diet, environmental conditions, and protocol design ERR agonist effects appear to be synergistic with concurrent exercise in animal models Compound handling and capsule storage should be standardized across a study Co-administration with other ERR-active or mitochondria-targeting compounds has not been characterized Administration SLU-PP-332 in the 250 mcg capsule form is taken orally
Vitamin C is generally well-tolerated and suitable for all skin types when used in appropriate concentrations
(PubMed) Mirvish SS, Wallcave L, Eagen M, Shubik P
The compounds primary action involves modulating nitric oxide system activity, which helps stabilize the balance between vasodilation and vasoconstriction, especially in ischemic conditions